Literature DB >> 30182173

Genetic characteristics of the P1 coding region of Coxsackievirus A16 associated with hand, foot, and mouth disease in China.

Li Xu1,2, Dawei Cui3, Lei Wang2, Jun Cheng2, Changgui Sun2, Lanjuan Li1, Hongcui Cao4.   

Abstract

Coxsackievirus A16 (CVA16) is one of the major etiological agents of hand, foot, and mouth disease (HFMD) in young children. To investigate the genetic characteristics of the P1 coding region gene of CVA16 associated with HFMD in China, we included the sequences of CVA16 specimens obtained from outbreak investigations and sporadic HFMD cases between 1998 and 2014 in China from GenBank, we genotyped the CVA16 sequences and analyzed P1 coding region sequences that encode structural proteins with bioinformatics software. CVA16 was classified into genotypes A and B1 based on the VP1 gene; the B1b and B1a subgenotypes were the major CVA16 strains and predominated in the coastal areas of China. Four strains were found to show inter- and intra-typic recombination in the P1 region. The amino acid identities of VP1, VP2, VP3, and VP4 proteins in all Chinese CVA16 strains were 88.2-100%, 83.0-100%, 87.6-100%, and 72.4-100%, respectively. A total of 251 amino acid substitution sites were detected in the structural proteins encoded by the P1 coding region gene. The amino acid sequences of the P1 coding region in Chinese CVA16 strains were highly conserved, although some amino acid mutations occurred with high frequency: VP1-T11A (10%), N14S (14%), L23M/V (11%), T98M (16%), V107A (14%), N102D (6.1%), E145V (8.8%), N218D (10%), E241K (22%), T248A/I (6.8%); VP2-I217V (22%), T226A (38%); VP3-N141S/G (5.4%), and N240D (15%). The genetic characteristics of CVA16 in the P1 coding region gene may provide a basis for developing a CVA16 vaccine and preventing and controlling HFMD in China.

Entities:  

Keywords:  Coxsackievirus A16; Genetic characteristics; P1 coding region gene; Phylogenetic analysis; Variation

Mesh:

Year:  2018        PMID: 30182173     DOI: 10.1007/s11033-018-4345-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

1.  Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.

Authors:  Ke Lyu; Ya-Ling He; Hao-Yang Li; Rong Chen
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  Characterization of VP1 gene of coxsackievirus A16 prevalent among hand foot mouth disease suffered children in Taizhou, P. R. China, between 2010 and 2013.

Authors:  Zhilong Ma; Jie Zha
Journal:  J Med Virol       Date:  2015-07-17       Impact factor: 2.327

3.  Rates of spontaneous mutation among RNA viruses.

Authors:  J W Drake
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.

Authors:  Yicun Cai; Qingwei Liu; Xulin Huang; Dapeng Li; Zhiqiang Ku; Yunfang Zhang; Zhong Huang
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

5.  A survey of coxsackie A16 virus antibodies in human sera.

Authors:  G E Urquhart
Journal:  J Hyg (Lond)       Date:  1984-10

6.  A neonatal mouse model of coxsackievirus A16 for vaccine evaluation.

Authors:  Qunying Mao; Yiping Wang; Rong Gao; Jie Shao; Xin Yao; Shuhui Lang; Chao Wang; Panyong Mao; Zhenglun Liang; Junzhi Wang
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

7.  Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications.

Authors:  Wei Xu; Chun-feng Liu; Li Yan; Jiu-jun Li; Li-jie Wang; Ying Qi; Rui-bo Cheng; Xiao-yu Xiong
Journal:  Virol J       Date:  2012-01-09       Impact factor: 4.099

8.  Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants.

Authors:  Feng-Cai Zhu; Zheng-Lun Liang; Fan-Yue Meng; Ying Zeng; Qun-Ying Mao; Kai Chu; Xue-Fang Song; Xin Yao; Jing-Xin Li; Hong Ji; Yi-Ju Zhang; Liang Li; Hong-Xing Pan; Ke Xu; Wei-Ming Dai; Wei-Wei Zhang; Fei Deng; Hua Wang; Jun-Zhi Wang
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

9.  Comparative pathogenicity of Coxsackievirus A16 circulating and noncirculating strains in vitro and in a neonatal mouse model.

Authors:  L Huang; X Liu; J L Li; J L Chang; G C Liu; X F Yu; W Y Zhang
Journal:  Braz J Med Biol Res       Date:  2015-03-27       Impact factor: 2.590

10.  Detecting spatial-temporal clusters of HFMD from 2007 to 2011 in Shandong Province, China.

Authors:  Yunxia Liu; Xianjun Wang; Yanxun Liu; Dapeng Sun; Shujun Ding; Bingbing Zhang; Zhaohui Du; Fuzhong Xue
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more
  3 in total

1.  Molecular Epidemiology of Herpangina Children in Tongzhou District, Beijing, China, During 2019-2020.

Authors:  Ming-Zhu Xie; Lin-Yi Chen; Yan-Na Yang; Yan Cui; Si-Hui Zhang; Tian-Shuo Zhao; Wan-Xue Zhang; Juan Du; Fu-Qiang Cui; Qing-Bin Lu
Journal:  Front Med (Lausanne)       Date:  2022-04-25

2.  Genetic Variation of Multiple Serotypes of Enteroviruses Associated with Hand, Foot and Mouth Disease in Southern China.

Authors:  Yonghong Zhou; Le Van Tan; Kaiwei Luo; Qiaohong Liao; Lili Wang; Qi Qiu; Gang Zou; Ping Liu; Nguyen To Anh; Nguyen Thi Thu Hong; Min He; Xiaoman Wei; Shuanbao Yu; Tommy Tsan-Yuk Lam; Jie Cui; H Rogier van Doorn; Hongjie Yu
Journal:  Virol Sin       Date:  2020-07-28       Impact factor: 4.327

3.  Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.

Authors:  Huiqiang Wang; Tingting Guo; Yajun Yang; Lian Yu; Xiandao Pan; Yuhuan Li
Journal:  Front Cell Infect Microbiol       Date:  2019-08-07       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.